Health - Google News: Independent monitor says Celgene cancer drug meets late-stage goals - Reuters

Health - Google News Google News

Independent monitor says Celgene cancer drug meets late-stage goals - Reuters Oct 23rd 2012, 13:30 Independent monitor says Celgene cancer drug meets late-stage goals Reuters (Reuters) - Independent safety monitors determined that Celgene Corp's experimental cancer drug met the main goal of a late stage trial of improving progression-free survival in multiple myeloma patients who have relapsed or not responded to prior ... Celgene wraps promising PhIII data on new multiple myeloma challengerFierceBiotech CELGENE CORPORATION : Celgene Myeloma Treatment Meets Primary ...4-traders all 24 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: